Chi3l1 deficiency can ameliorate AD by reducing the amyloid-beta burden, restoring memory functions, and inhibiting neuroinflammation via blockade of the ERK-dependent PTX3 pathway [163,301]. The gene discussed is PTX3; the disease is Alzheimer disease.